Methotrexate-Related Epstein-Barr Virus (EBV)-Associated Lymphoproliferative Disorder-So-Called "Hodgkin-Like Lesion"-of the Oral Cavity in a Patient with Rheumatoid Arthritis

Head and Neck Pathology

Volumn 4, Issue 4, 2010, Pages 305-311

  Kikuchi, Kentaro ^a   Miyazaki, Yuji ^a   Tanaka, Akio ^a   Shigematu, Hisao ^a   Kojima, Masaru ^b   Sakashita, Hideaki ^a   Kusama, Kaoru ^a  

^a MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus (EBV); Hodgkin like lesion; Methotrexate related Epstein Barr virus associated lymphoproliferative disorder (MTX EBVLPD); Oral cavity; Rheumatoid arthritis (RA)

Indexed keywords

ANTIRHEUMATIC AGENT; METHOTREXATE; VIRUS RNA;

AGED; ARTICLE; BIOPSY; CASE REPORT; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LYMPHOPROLIFERATIVE DISEASE; MOUTH; PATHOLOGY; RHEUMATOID ARTHRITIS; VIROLOGY;

AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOPSY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; METHOTREXATE; MOUTH; RNA, VIRAL;

EID: 78650061830     PISSN: 1936055X     EISSN: 19360568     Source Type: Journal    
DOI: 10.1007/s12105-010-0202-6     Document Type: Article

References (20)

1. Daniel M, Knowles MD. Immunodeficiency-associated lymphoproliferative disorders. Mod Pathol. 1999; 12: 200-17.
2. Tishler M, Caspi D, Yaron M. Long-term experience with low dose methotrexate in rheumatoid arthritis. Rheumatol Int. 1993; 13: 103-6.
3. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with metotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol. 1996; 14: 1943-9.
4. Mariette X, Cazals-Hatem D, Warszawki J, et al. Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France. Blood. 2002; 99: 3909-15.
5. Menke DM, Griesser H, Moder KG, et al. Comparison of p53 protein expression and latent EBV infection in patients immunosuppressed and not immunosuppressed with methotrexate. Am J Clin Pathol. 2000; 113: 212-8.
6. Kojima M, Itoh H, Hirabayashi K, et al. Methotrexate-associated lymphoproliferative disorders: a clinicopathological study of 13 Japanese case. Pathol Res Pract. 2006; 202: 679-85.
7. Tanaka A, Shigematsu H, Kojima M, et al. Methotrexate-associated lymphoproliferative disorder arising in a patient with adult Still's disease. J Oral Maxillofac Surg. 2008; 66: 1492-5.
8. Dojcinov SD, Venkataraman G, Raffeld M, et al. EBV positive mucocutaneous ulcer-a study of 26 cases associated with various sources of immunosuppression. Am J Surg Pathol. 2010; 34: 405-17.
9. Uneda S, Sonoki T, Nakamura Y, et al. Rapid vanishing of tumors by withdrawal of methotrexate in Epstein-Barr virus-related B cell lymphoproliferative disorder. Inter Med. 2008; 47: 1445-6.
10. Kamel OW, Weiss LM, Rijn M, et al. Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy. Am J Surg Pathol. 1996; 20: 1279-87.
11. Lee MA, Hong YS, Kang JH, et al. Detection of Epstein-Barr virus by PCR and expression of LMP1, p53, CD44 in gastric cancer. Korean J Intern Med. 2004; 19: 43-7.
12. Chen CH, Liu HC, Hung TT, et al. Possible roles of Epstein-Barr virus in Castleman disease. J Cardiothorac Surg. 2009; 4: 31.
13. Thomas E, Brewster DH, Black RJ, et al. Risk of malignancy among patients with rheumatic conditions. Int J Cancer. 2000; 88: 497-502.
14. Silman AJ, Petrie J, Hazleman B, et al. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20-year follow-up study. Ann Rheum Dis. 1988; 47: 988-92.
15. Gandhi MK, Tellam JT, Khanna R. Epstein-Barr virus-associated Hodgkin's lymphoma. Br J Haematol. 2004; 125: 267-81.
16. Asano N, Yamamoto K, Tamaru J, et al. Age-related Epstein-Barr virus (EBV)-associated B-cell lymphoproliferative disorders: comparison with EBV-positive classic Hodgkin lymphoma in elderly patients. Blood. 2009; 113: 2629-36.
17. Delecluse HJ, Marafioti T, Hummel M, et al. Disappearance of the Epstein-Barr virus in a relapse of Hodgkin's disease. J Pathol. 1997; 182: 475-9.
18. Nerurkar AY, Vijayan P, Srinivas V, et al. Discrepancies in Epstein-Barr virus association at presentation and relapse of classical Hodgkin's disease: impact on pathogenesis. Annal Oncol. 2000; 11: 475-8.
19. Tosato G, Steinberg AD, Yarchoan R, et al. Abnormally elevated frequency of Epstein-Barr virus-infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest. 1984; 73: 1789-95.
20. Wolfe F, Michaud K. The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19, 562 patients during 89, 710 person-years of observation. Arthritis Rheum. 2007; 56: 1433-9.